Advanced search
Publication Cover
Current Eye Research Volume 43, 2018 - Issue 2
Submit an article Journal homepage
284
Views
37
CrossRef citations to date
0
Altmetric
Original Articles

One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema

Fengjiao LiDepartment of Ophthalmology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
,
Le ZhangDepartment of School of public health, Taishan Medical University, Taian, China
,
Yanling WangDepartment of Ophthalmology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing, China
,
Wenwen XuDepartment of Ophthalmology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
,
Wanzhen JiaoDepartment of Ophthalmology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
,
Aihua MaDepartment of Pediatrics, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
&
Bojun ZhaoDepartment of Ophthalmology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, ChinaCorrespondence[email protected] [email protected]
 show all
Pages 218-223 | Received 15 Feb 2017, Accepted 11 Sep 2017, Published online: 21 Dec 2017

References

  • Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17. doi:10.1186/s40662-015-0026-2.
  • Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–77. doi:10.1111/ceo.12696.
  • Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–25. doi:10.1016/j.ophtha.2011.01.031.
  • Elman MJ, Ayala A, Bressler NM, Browning D, Flaxel CJ, Glassman AR, Jampol LM, Stone TW. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. Ophthalmology. 2015;122(2):375–81. doi:10.1016/j.ophtha.2014.08.047.
  • Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, Boos CJ, Xing W, Egan C, Peto T, et al. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology. 2010;117(6):1078–1086.e2. doi:10.1016/j.ophtha.2010.03.045.
  • Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, et al. Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies. Ophthalmology. 2015;122(10):2044–52. doi:10.1016/j.ophtha.2015.06.017.
  • Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, et al. One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology. 2012;119(8):1658–65. doi:10.1016/j.ophtha.2012.02.010.
  • Dugel PU, Hillenkamp J, Sivaprasad S, Vogeler J, Mousseau MC, Wenzel A, Margaron P, Hashmonay R, Massin P. Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials. Clinical Ophthalmology. 2016;10:1103–10. doi:10.2147/OPTH.
  • Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–203. doi:10.1056/NEJMoa1414264.
  • Lu X, Sun X. Profile of conbercept in the treatment of neovascular age-related macular degeneration. Drug Des Devel Ther. 2015;9:2311–20.
  • Qu J, Cheng Y, Li X, Yu L, Ke X, Group AS. Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: subgroup Analysis of the Aurora Study. Retina. 2016;36(5):926–37. doi:10.1097/IAE.0000000000000875.
  • Li F, Sun M, Guo J, Ma A, Zhao B. Comparison of conbercept with ranibizumab for the treatment of macular edema secondary to branch retinal vein occlusion. Curr Eye Res. 2017 Apr;25:1–5.
  • Grant MB, Afzal A, Spoerri P, Pan H, Shaw LC, Mames RN. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin Investig Drugs. 2004;13(10):1275–93. doi:10.1517/13543784.13.10.1275.
  • Ashraf M, Souka A, Adelman R, Forster SH. Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option. Eye. 2016;30:1531–41. doi:10.1038/eye.2016.174.
  • Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, et al. Association of baseline visual acuity and retinal thickness with 1-year efficacy of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema. JAMA Ophthalmol. 2016;134(2):127–34. doi:10.1001/jamaophthalmol.2015.4599.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.